Katie Stamp

SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate

Mary E. Matyskiela, Suzana S. Couto, Xinde Zheng et al. · Nature Chemical Biology · 2018 · 327 citations

Mutagenesis, Thalidomide-dependent Cereblon Substrate, Biochemistry

Hospital use for potentially preventable conditions in Aboriginal and Torres Strait Islander and other Australian populations

Katie Stamp, Stephen Duckett, Dale Fisher · Australian and New Zealand Journal of Public Health · 1998 · 45 citations

Nursing, Hospitalization, Preventive Medicine +8

Target organ toxicities in studies conducted to support first time in man dosing: An analysis across species and therapy areas

Steve Horner, David P. Ryan, Sally Robinson et al. · Regulatory Toxicology and Pharmacology · 2013 · 41 citations

Man Dosing, Target Organ Toxicities, Medicine +10

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

Comparison of Computerized Image Analysis with Traditional Semiquantitative Scoring of Perls’ Prussian Blue Stained Hepatic Iron Deposition

Andrew Hall, Wendy J. Davies, Katie Stamp et al. · Toxicologic Pathology · 2013 · 28 citations